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confusion over the proper units (e.g. micrograms/milligrams),
prohibition of certain drugs for infants and poor compliance by
children Little is written in the medical literature concerning
errors in prescribing children’s medications in the community;
most reports focus on hospital prescribing habits. OBJECTIVES:
To evaluate the quality of community pediatricians’ prescrip-
tions. METHODS: On 13 randomly chosen days during a 10
month period (December, 2003 until October, 2004), a total of
312 prescriptions written by 54 pediatricians were reviewed in
four different pharmacies in the Shfela District of Macabi
Health-Care Services. The following criteria were used: the cor-
relation of the treatment prescribed to the diagnosis as stated in
the computerized medical record and the appropriateness of the
dosage for the child’s age and weight. A correct prescription was
deﬁned as one which met these criteria. An incorrect prescrip-
tion lacked one or both of these qualities. RESULTS: From the
312 prescriptions that were evaluated, 265 (83.9%) were found
to be properly written. In 29 (9.3%) the treatment prescribed
did not correlate to the recorded diagnosis, and in one (0.3%)
the dosage was incorrect. In three (0.9%) prescriptions, no
dosage was stipulated at all. In an additional 18 (5.7%), techni-
cal failures of the computerized ﬁle precluded seeing a diagno-
sis. CONCLUSION: A total of 83.9% of the prescriptions that
were reviewed were properly written. In most of those that failed
to correlate with the diagnosis, treatment was provided sympto-
matically (nose drops, antipyretic, etc.) As a result of this study,
technical failures that were identiﬁed in the information systems
were repaired. Physicians were provided information detailing
the proper use and dosage of symptomatic medications accord-
ing to age and weight.
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OBJECTIVES: To assess the utility of a new Health Employer
Data and Information Set (HEDIS) measure of quality of care 
of pediatric upper respiratory infections (URI) in an Israeli
HMO, develop a comparable measure, and estimate baseline
performance. METHODS: Data sources included physician 
visit and pharmacy purchase ﬁles. We selected physician visits 
in 2003 bearing diagnoses corresponding to ICD-9-CM 460 
(URI-nasopharyngitis), 465 (URI other/unspeciﬁed site), and 461
(sinusitis) among children ages three-months to 18 years. Visits
by children for whom antibiotics had been purchased in the pre-
ceding 30 days, or who had additional diagnoses were excluded.
Associated antibiotic use was deﬁned as purchase of any antibi-
otic prescribed by the physician who recorded the URI diagno-
sis within three days of the visit. RESULTS: A total of 160,781
ﬁrst encounters for URI or sinusitis met the inclusion criteria.
Nine percent were associated with an antibiotic purchase.
Antibiotic use for URI or sinusitis increased with age, from 4%
of visits in children under the age of one to 14% in children ages
15–18. Sixty-two percent of sinusitis, 7.1% of “nasopharyngi-
tis,” and 32% of “unspeciﬁed URI” visits were associated with
antibiotic use. CONCLUSION: Transfer of quality measures
between medical systems requires consideration of differences in
medical practice and of the ways in which diagnoses are used
and coded. In adapting the HEDIS measures of care of pediatric
upper respiratory infections, we chose to examine prescribing
practices within subgroups, as well as to explore sinusitis treat-
ment, an issue not currently addressed by HEDIS measures.
Overall antibiotic use in conjunction with diagnosis of URI in
our population was comparable to reported ﬁgures in US com-
mercial and Medicaid plans for the same year, but varied with
age and speciﬁc diagnosis. Additional attention to sinusitis treat-
ment, not currently addressed by HEDIS, is warranted.
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OBJECTIVES: To assess the utility of a new Health Employer
Data and Information Set (HEDIS) measure for care quality in
treatment of pediatric pharyngitis in an Israeli HMO, develop 
a comparable measure, and estimate baseline performance.
METHODS: Data sources included physician visit, pharmacy
purchase and laboratory result ﬁles. We selected physician visits
in 2003 bearing diagnoses corresponding to ICD-9-CM groups
034, 462 and 463 among children ages two to 18 years. Visits
by children for whom antibiotics had been purchased in the pre-
ceding 30 days or who had additional diagnoses were excluded.
Antibiotic treatment was deﬁned as purchase within three days
of the visit of any antibiotic prescribed by the physician who
recorded the diagnosis of pharyngitis. The ﬁrst encounter
meeting inclusion criteria for each child was selected. Testing for
streptococcal infection was deﬁned as a throat culture or rapid
strep test in laboratory ﬁles, or record of throat swab or rapid
test during a visit, any time from three days prior to the visit
until three days after the visit. RESULTS: Fifty-one percent of
visits for pharyngitis among children ages 2–18 years were asso-
ciated with an antibiotic prescription. A total of 76,399 ﬁrst
encounters for pharyngitis were associated with antibiotic treat-
ment in 2003; 34% were accompanied by strep testing. Fre-
quency of testing varied by administrative region, from 30% to
39%. CONCLUSIONS: Utilization of strep testing in associa-
tion with antibiotic treatment of pediatric pharyngitis (as 
measured according to HEDIS criteria) was low in Maccabi
Healthcare Services in 2003 in comparison to performance in US
commercial and Medicaid health plans. In calculating this
measure, we assumed complete reporting of rapid strep tests per-
formed in physicians’ ofﬁces. Reﬁnement of this measure will
require verifying this assumption, as underreporting by physi-
cians would result underestimation of performance.
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OBJECTIVES: This study determined the prevalence of poten-
tially inappropriate medication use in a nationally representative
sample of the non-institutionalized elderly population using the
updated Beers 2003 criteria. METHODS: Participants with age
65 years and older were selected from the Medical Expenditure
Panel Survey (MEPS) panel ﬁve for the period of January, 2000
to December, 2001, which was constituted by a series of ﬁve-
round interviews. The average duration within each round was
3.5, 5.0, 6.0, 6.0, and 3.5 months from round one to ﬁve, respec-
tively. Potentially inappropriate prescription medications were
identiﬁed using the NDC (National Drug Code). All the calcu-
lations of prevalence were adjusted by the weight variable in the
MEPS. RESULTS: Among the 1161 elderly participants in panel
